Search results
Results From The WOW.Com Content Network
Glaucoma in a dog. Canine glaucoma refers to a group of diseases in dogs that affect the optic nerve and involve a loss of retinal ganglion cells in a characteristic pattern. . An intraocular pressure greater than 22 mmHg (2.9 kPa) is a significant risk factor for the development of glauco
Ocular hypertension is the presence of elevated fluid pressure inside the eye (intraocular pressure), usually with no optic nerve damage or visual field loss. [1] [2]For most individuals, the normal range of intraocular pressure is between 10 mmHg and 21 mmHg. [3]
Aggression: When a dog presents with aggression, we have to examine all of the potential causes (a medical problem like a seizure condition, poor socialization, poor nutrition (1), high prey drive ...
Skin conditions in dogs are very common, so it's important to recognize the symptoms and understand the factors that cause them. Dr. Rebecca MacMillan, a vet with over 15 years of experience, says ...
Intraocular pressure laws follow fundamentally from physics. Any kinds of intraocular surgery should be done by considering the intraocular pressure fluctuation. Sudden increase of intraocular pressure can lead to intraocular micro barotrauma and cause ischemic effects and mechanical stress to retinal nerve fiber layer. Sudden intraocular ...
Symptoms in dogs include acute arthritis, anorexia and lethargy. There is no rash as is typically seen in humans. [11] Ehrlichiosis is a disease caused by Ehrlichia canis and spread by the brown dog tick, Rhipicephalus sanguineus. Signs include fever, vasculitis, and low blood counts. [6]
Posner–Schlossman syndrome (PSS) also known as glaucomatocyclitic crisis (GCC) is a rare acute ocular condition with unilateral attacks of mild granulomatous anterior uveitis and elevated intraocular pressure. It is sometimes considered as a secondary inflammatory glaucoma.
Secondary glaucoma is a collection of progressive optic nerve disorders associated with a rise in intraocular pressure (IOP) which results in the loss of vision. In clinical settings, it is defined as the occurrence of IOP above 21 mmHg requiring the prescription of IOP-managing drugs. [ 1 ]